ISRG Lower PT to $500 from $590 but remain Buy rated as Q2 results surpassed consensus, however ACA headwinds turned management incrementall

ISRG Lower PT to $500 from $590 but remain Buy rated as Q2 results surpassed consensus, however ACA headwinds turned management incrementally conservative on procedures @ Citi